Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

Article Abstract:

A multicenter, randomized, double-blind, placebo-controlled trial was conducted to determine whether the addition of intravenous methylprednisolone to conventional primary therapy for Kawasaki disease reduces the risk of coronary-artery abnormalities. The result data do not provide support for the addition of a single dose of pulsed intravenous methylprednisolone to conventional therapy in the routine primary treatment of Kawasaki disease.

Author: Sleeper, Lynn A., Newburger, Jane W., McCrindle, Brian W., Minich, L. LuAnn
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Diagnosis, Corticosteroids, Kawasaki disease, Kawasaki syndrome, Corticosteroid drugs, Disease/Disorder overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Tolvaptan, a selective oral vasopressin [V.sub.2]-receptor antagonist, for hyponatremia

Article Abstract:

A study was conducted to investigate the effect of tolvaptan, an orally active vasopressin [V.sub.2]-receptor antagonist on predicting acute and chronic hyponatremia, which is used to predict death among patients with chronic heart failure and cirrhosis. The results show that tolvaptan, when added to standard therapy, despite consistent side effects, is of great help in raising and maintaining serum sodium concentrations in the patients.

Author: Schrier, Robert W., Berl, Tomas, Gross, Peter, Verbalis, Joseph G., Orlandi, Cesare
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Complications and side effects, Dosage and administration, Vasopressin, Vasopressins, Drug overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hyponatremia among runners in the Boston marathon

Article Abstract:

A cohort of marathon runners is studied to estimate the incidence of hyponatremia and to identify the principal risk factors. Considerable weight gain while running, a long racing time, and body-mass-index extremes were associated with hyponatremia, whereas female sex, composition of fluids ingested, and use of nonsteroidal antiflammatory drugs were not.

Author: Newburger, Jane W., Wypij, David, Almond, Christopher S. D., Shin, Andrew Y., Fortescue, Elizabeth B., Mannix, Rebekah C., Binstadt, Bryce A., Duncan, Christine N., Olson, David P., Salerno, Ann E., Greenes, David S.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
United Kingdom, Usage, Nonsteroidal anti-inflammatory drugs, Nonsteroidal anti-inflammatory agents, Runners (Sports)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Risk factors, Drug therapy, Hyponatremia
Similar abstracts:
  • Abstracts: Use of inhaled corticosteroids and the risk of cataracts. Blood pressure. Hypertensive retinopathy
  • Abstracts: A need to see the patient rather than their offence. The effect of witnessing death
  • Abstracts: On behalf of older women: another reason to protect Medicare and Medicaid. A potential decline in life expectancy in the United States in the 21st century
  • Abstracts: Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage
  • Abstracts: Notice to readers: Caution regarding testing for Lyme disease
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.